Consistency Between Oscillometry and Spirometry in Patients with Suspected or Confirmed COPD or Asthma: Results from a Multi-Center Study in China.

IF 2.1 4区 医学 Q3 RESPIRATORY SYSTEM
Hongtao Niu, Xiajun Rong, Min Zhang, Fei Deng, Liang Zhang, Yong Li, Yi Gao, Tim Harrison, Samuel Bardsley, Yuanlin Song, Kewu Huang, Ting Yang, Chen Wang
{"title":"Consistency Between Oscillometry and Spirometry in Patients with Suspected or Confirmed COPD or Asthma: Results from a Multi-Center Study in China.","authors":"Hongtao Niu, Xiajun Rong, Min Zhang, Fei Deng, Liang Zhang, Yong Li, Yi Gao, Tim Harrison, Samuel Bardsley, Yuanlin Song, Kewu Huang, Ting Yang, Chen Wang","doi":"10.1080/15412555.2026.2617284","DOIUrl":null,"url":null,"abstract":"<p><p>Spirometry is the standard for assessing airflow obstruction but can be challenging and/or time-consuming for patients. Oscillometry offers an effort-independent alternative. This study assessed the consistency between oscillometry and spirometry in Chinese patients with suspected or confirmed chronic obstructive pulmonary disease (COPD) or asthma. This prospective study enrolled patients from 46 Chinese hospitals. All underwent oscillometry with the Ambulatory Lung Diagnosis System followed by spirometry, both before and after salbutamol. The primary outcome was prebronchodilator (pre-BD) test consistency (normal vs. abnormal), evaluated using Cohen's Kappa. Secondary outcomes included the number of attempts to complete each test, post-BD consistency in the COPD group, and BD test consistency overall. From February 8 and August 30, 2024, 801 patients were enrolled; 788 completed both tests and were analyzed (COPD: 197 suspected, 194 confirmed; asthma: 200 suspected, 197 confirmed). Pre-BD results showed moderate test consistency (kappa = 0.4188, 95% CI: 0.3556-0.4820; overall agreement = 70.9%). Overall BD test had only fair agreement (kappa = 0.2722, 95% CI: 0.1870-0.3575; overall agreement = 80.3%) between tests. Post-BD results in the COPD group showed moderate consistency between tests (kappa = 0.4662, 95% CI: 0.3803-0.5521; overall agreement = 73.6%), with a high positive predictive value (87.4%) of abnormal oscillometry for spirometrydefined COPD. For satisfactory results, oscillometry required significantly fewer attempts than spirometry (mean: 8.5 vs. 11.0, <i>p</i> < 0.0001). While oscillometry showed only moderate consistency with spirometry, its high positive predictive value suggests potential as a rule-in test for COPD diagnosis when spirometry is not feasible. An alternative oscillometry-based diagnostic pathway may help improve COPD diagnosis under such circumstances.</p><p><strong>Clinical trial registration: </strong>ClinicalTrials.gov (NCT06172777).</p>","PeriodicalId":10704,"journal":{"name":"COPD: Journal of Chronic Obstructive Pulmonary Disease","volume":"23 1","pages":"2617284"},"PeriodicalIF":2.1000,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"COPD: Journal of Chronic Obstructive Pulmonary Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/15412555.2026.2617284","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/20 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Spirometry is the standard for assessing airflow obstruction but can be challenging and/or time-consuming for patients. Oscillometry offers an effort-independent alternative. This study assessed the consistency between oscillometry and spirometry in Chinese patients with suspected or confirmed chronic obstructive pulmonary disease (COPD) or asthma. This prospective study enrolled patients from 46 Chinese hospitals. All underwent oscillometry with the Ambulatory Lung Diagnosis System followed by spirometry, both before and after salbutamol. The primary outcome was prebronchodilator (pre-BD) test consistency (normal vs. abnormal), evaluated using Cohen's Kappa. Secondary outcomes included the number of attempts to complete each test, post-BD consistency in the COPD group, and BD test consistency overall. From February 8 and August 30, 2024, 801 patients were enrolled; 788 completed both tests and were analyzed (COPD: 197 suspected, 194 confirmed; asthma: 200 suspected, 197 confirmed). Pre-BD results showed moderate test consistency (kappa = 0.4188, 95% CI: 0.3556-0.4820; overall agreement = 70.9%). Overall BD test had only fair agreement (kappa = 0.2722, 95% CI: 0.1870-0.3575; overall agreement = 80.3%) between tests. Post-BD results in the COPD group showed moderate consistency between tests (kappa = 0.4662, 95% CI: 0.3803-0.5521; overall agreement = 73.6%), with a high positive predictive value (87.4%) of abnormal oscillometry for spirometrydefined COPD. For satisfactory results, oscillometry required significantly fewer attempts than spirometry (mean: 8.5 vs. 11.0, p < 0.0001). While oscillometry showed only moderate consistency with spirometry, its high positive predictive value suggests potential as a rule-in test for COPD diagnosis when spirometry is not feasible. An alternative oscillometry-based diagnostic pathway may help improve COPD diagnosis under such circumstances.

Clinical trial registration: ClinicalTrials.gov (NCT06172777).

在疑似或确诊COPD或哮喘患者中振荡测定法和肺活量测定法的一致性:来自中国一项多中心研究的结果
肺活量测定法是评估气流阻塞的标准,但对患者来说可能具有挑战性和/或耗时。振荡测量法提供了一种不需要费力的替代方法。本研究评估了中国疑似或确诊慢性阻塞性肺疾病(COPD)或哮喘患者的振荡测定法和肺活量测定法的一致性。这项前瞻性研究纳入了来自46家中国医院的患者。在沙丁胺醇治疗前后,所有患者均采用动态肺诊断系统进行振荡测量,然后进行肺活量测定。主要终点是支气管扩张剂前(bd前)测试一致性(正常与异常),使用Cohen's Kappa进行评估。次要结局包括完成每次测试的尝试次数、COPD组BD后的一致性以及总体BD测试的一致性。2024年2月8日至8月30日,入组801例患者;788人完成了两项检测并进行了分析(疑似慢性阻塞性肺病197人,确诊194人;疑似哮喘200人,确诊197人)。bd前结果显示中等程度的一致性(kappa = 0.4188, 95% CI: 0.3556-0.4820;总体一致性= 70.9%)。总体BD测试在测试之间只有公平的一致性(kappa = 0.2722, 95% CI: 0.1870-0.3575;总体一致性= 80.3%)。COPD组bd后结果在两项测试之间显示出中等程度的一致性(kappa = 0.4662, 95% CI: 0.3803-0.5521;总体一致性= 73.6%),对于肺量测定法定义的COPD,振荡测量异常具有较高的阳性预测值(87.4%)。为了获得满意的结果,振荡测量法比肺活量测定法需要的尝试次数要少得多(平均值:8.5 vs 11.0, p)。临床试验注册:ClinicalTrials.gov (NCT06172777)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.40
自引率
0.00%
发文量
38
审稿时长
6-12 weeks
期刊介绍: From pathophysiology and cell biology to pharmacology and psychosocial impact, COPD: Journal Of Chronic Obstructive Pulmonary Disease publishes a wide range of original research, reviews, case studies, and conference proceedings to promote advances in the pathophysiology, diagnosis, management, and control of lung and airway disease and inflammation - providing a unique forum for the discussion, design, and evaluation of more efficient and effective strategies in patient care.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书